This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Finch A et al. (2006) Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. JAMA 296: 185–192
Finch A et al. (2006) Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gyn Oncol 100: 58–64
Piek JM et al. (2004) Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause. Am J Obstet Gynecol 191: 718–732
Guillem JG et al. (2006) ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Clin Oncol 24: 4642–4660
Rocca WA et al. (2006) Survival patterns after oophorectomy in pre-menopausal women: a population-based cohort study. Lancet Oncology 10: 821–828
Powel CB (2006) Occult ovarian cancer at the time of risk-reducing salpingo-oophorectomy. Gyn Oncol 100: 1–2
Acknowledgements
The synopsis was written by Mandy Aujla, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Morgan, M. The main site of origin for malignancies detected during risk-reducing surgery for ovarian cancer. Nat Rev Clin Oncol 5, 134–135 (2008). https://doi.org/10.1038/ncponc1040
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncponc1040